SEC Sues Akebia Manager For Insider Trading On Drug Report
The U.S. Securities and Exchange Commission on Tuesday sued a director of biopharmaceutical company Akebia Therapeutics Inc., claiming that he bought shares and tipped off his wife and friend ahead of...To view the full article, register now.
Already a subscriber? Click here to view full article